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Introduction and aim: The aim of the thesis was to revise the medical documentation in 
the aftercare health facility, to classify the identified drug related problems (DRP) and to 
describe the chosen DRP by the SAZE principals.
Methodology:  The data collection for this thesis took place in ONLP in the time period 
from the 27th of August to the 30th of August 2019. The aim of the auditors was a revision 
of  phamacotherapy  of  all  76  patients.  A  complete  electronic  and  printed  medical 
documentation was provided. The DRP were identified based on the information about 
a patient and described by the SAZE principals. The DRP were reported in the electronic 
database  according  to  the  modified  PCNE  classification V5.01.  All  obtained  data  was 
exported to the Microsoft Office Excel in the form of tables and processed by freqency 
analysis. Six case studies with the detailed description of the patient and the pharmacist´s  
analysis  by  the  SAZE  principals  were  demonstrated.  The  conclusion  of  the  audit  was 
presented to doctors and the DRP were discussed at educational seminar. 
Results: From total of 76 patients, the majority were women (65.8 %). There were mostly 
patients aged over 65 years (89.5 %). All patients were taking 669 drugs, of which the 
majority were drugs for the therapy of nervous (29.4 %) and cardiovascular (CV) system 
(26.7 %). Each patient used 8.8 drugs on the average. A total amount of identified DRP 
was 295. Each patient experienced 3.9 DRP on the average. The most common type of the 
DRP was P2–problem with the choise of the drug (48.1 %).
Conclusion:  The medical documentation was revised which focused on DRP.  To increase 
the  quality  of  medical  care,  the  periodical  revisions  of  the  pharmacotherapy,  ideally 
implemented  by  a  clinical  phamacist  associated  with  the  education  of  healthcare 
professionals in the facility, would be useful. The result should be the involvement of the 
clinical pharmacist in the professional team that cares of the patients.
